Safety and biological activity of repeated doses of recombinant human Flt3 ligand in patients with bone scan-negative hormone-refractory prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/14977818

Clin. Cancer Res. 2004 Feb 15 10 4 1219-25

Download in:

View as

General Info

PMID
14977818